School of Medicine
Showing 161-170 of 177 Results
-
Yufan (Fred) Wu
Affiliate, Dean's Office Operations - Dean Other
Resident in Radiation Oncology - Radiation TherapyCurrent Research and Scholarly InterestsPeer review:
- International Journal of Radiation Oncology, Biology, Physics (Red Journal) resident peer reviewer
- Ad hoc reviewer for journal manuscripts, Muscle & Nerve Journal
- Peer reviewer for conference abstracts, UCSF Department of Family & Community Medicine Rodnick Colloquium
Google Scholar profile (list of publications):
https://scholar.google.com/citations?hl=en&user=scgY1ecAAAAJ -
Jinxi Xiang
Postdoctoral Scholar, Radiation Physics
Current Research and Scholarly InterestsI develop machine leanring methods to autonomate the digital pathology.
-
Lei Xing
Jacob Haimson and Sarah S. Donaldson Professor and Professor, by courtesy, of Electrical Engineering
Current Research and Scholarly Interestsartificial intelligence in medicine, medical imaging, Image-guided intervention, molecular imaging, biology guided radiation therapy (BGRT), treatment plan optimization
-
Xiaohan Xing
Postdoctoral Scholar, Radiation Physics
BioXiaohan Xing is a Postdoctoral researcher at the Department of Radiation Oncology, Stanford University. Before joining Stanford, she worked as a Postdoctoral researcher at the City University of Hong Kong. She obtained her Ph.D. degree from The Chinese University of Hong Kong in 2021 and her B.S. degree from Shandong University in 2017.
Her research interests include medical image analysis, omics data analysis, and multi-modal based disease diagnosis. -
Jiangbin Ye
Assistant Professor of Radiation Oncology
Current Research and Scholarly InterestsOne hallmark of cancer is that malignant cells modulate metabolic pathways to promote cancer progression. My professional interest is to investigate the causes and consequences of the abnormal metabolic phenotypes of cancer cells in response to microenvironmental stresses such as hypoxia and nutrient deprivation, with the prospect that therapeutic approaches might be developed to target these metabolic pathways to improve cancer treatment.